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Dental implants have been widely used in partial or full edentulism for oral rehabilitation. 
Long-term prospective studies and systematic reviews have demonstrated that more than 
95% survival rate could be expected after 5-year of loading.1, 2 However, several etiologies 
might still contribute to early or late failure of dental implants such as biological, 
mechanical or iatrogenic factors.2-4 
Criteria to determine survival and success of dental implants have been reported in several 
studies.5-8 Based on the International Congress of Oral Implantologists (ICOI) Pisa 
Consensus Conference report,7 survival represents that the implant is still kept in the mouth 
instead of being removed, and should not present any mobility, pain on function or bone 
loss more than 1/2 of implant length. Albrektsson et al.5 defined that a successful implant 
must present no mobility, no peri-implant radiolucency, bone loss less than 0.2 mm per 
year after the first year of loading, and no persistent pain, discomfort or infection. Failure of 
a dental implant is determined when an implant is with mobility, pain on function, 
uncontrolled exudates, or severe bone loss.7 In this case, the implant should be removed. 
The concept of “osseointegration,” defined as “a direct functional and structural connection 
between living bone and the surface of a load carrying implant,” was originally introduced 
by Dr. Branemark.9 This finding has further influenced the evolution of implant dentistry 
on implant surface modifications, grafting procedures, bone substitutes, and surgical 
techniques. However, even with advancement of implant dentistry, early implant failure 
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still occurs and mostly involves in failure of achieving osseointegration during initial 
healing process after implant placement. This failure might result from poor bone quality or 
quantity, patient’s medical condition, smoking status, infection, overheating of the bone, 
compression bone necrosis, lack of primary stability as well as poor experience and skills 
of surgeons.10, 11  
On the contrary, late implant failure is related to unfavorable loading or occlusion, peri-
implant diseases and non-ideal prosthetic designs.11 Fu et al.12 elaborated occlusal 
considerations and management of complications when restoring a dental implant. In this 
article, the authors summarized that implant stability, radiographic bone loss (RBL), loss of 
attachment, and loosening and fractures of implant fixtures and prosthetic components, 
could be attributed to occlusal overloading. Although most of the mechanical/prosthetic 
complications are reversible by means of replacement or adjustment of restorative 
counterparts, currently there is still a lack of effective treatment modalities for managing 
biological complications such as peri-implantitis.13, 14  
Several local and systemic factors have been proposed and associated with an increased 
risk of peri-implantitis, for examples, smoking,15, 16 diabetes,17 previous history of 
periodontal diseases,15, 16, 18 poor plaque control19 and occlusal overload.12 Other 
predisposing local factor related to peri-implantitis is retained excess cement, which leads 
to potential biological complications and marginal bone loss.20, 21 It has been reported that a 
trend of bone loss exceeding 2 mm was found more in cement-retained restorations 
compared to screw-retained restorations,21 which may compromise the future survival of 
the implants and restorations. In a previously published cross-sectional study, Schwarz et 
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al.22 introduced binary logistic regression to assess the correlation with systemic factors. 
The results of the study showed that plaque (odds ratio, OR= 8.415) and gender “male” 
(OR= 2.003) were significantly correlated with the event peri-implant mucositis. In 
addition, plaque (OR= 9.250) and smoking (OR= 2.679) were significantly correlated with 
peri-implantitis. However, this study reviewed periodontal parameters and patients’ 
systemic conditions, but not restorative- and implant-related factors. Another recently 
published study by Renvert et al.23 also facilitated bivariate logistic regression model to 
analyze contributing factors related to peri-implantitis. Results of this study showed that 
OR of having peri-implantitis and a history of cardiovascular disease was 8.7, and OR of 
having a history of periodontitis was 4.5. Interestingly, smoking was not identified as a 
significant factor contributing to the outcome. Though these studies have examined the 
systemic factors and their association with peri-implant diseases, however, a 
comprehensive statistical modeling of patients' systemic, surgical as well as restorative 
risks has not been conducted in the literature. Therefore, the primary aim was to establish 
the ORs of various risks related to implant success. The secondary aim was to analyze the 





II. Study Aim 
The aim of this retrospective study was to study the ORs of various risks related to implant 







Implants placed in patients with systemic/local contributing factors, such as smoking, 
diabetes, previous history of periodontal diseases, poor plaque control, bone augmented 
sites, less experienced surgeons, and cement-retained multi-unit restorations, are more 






IV. Materials and Methods 
1. Data Retrieval  
In this retrospective study, the clinical charts and radiographs of patients who underwent 
dental implant placement at the University of Michigan School of Dentistry (UMSOD) 
since year 2000 were reviewed. Records with periapical or bitewing radiographs taken at 
the time of prosthesis placement and at least one year after implant restoration were 
included. Two hundreds cases were planned to be included in this retrospective 
radiographic study. The charts were reviewed in a chronological order starting from March 
2000 by a single examiner (GL) until 200 cases were selected based on the inclusion 
criteria (Figure I). Data regarding patients’ demographic data, including study number, 
implant location, age, gender, faculty/resident provider and provider department, were 
recorded. Information of patients’ systemic condition, including history of smoking status, 
diabetes mellitus, alcohol consumption, osteoporosis, depression, obesity, hypertension, 
and past history of periodontal diseases, were also retrieved during the chart review process. 
In addition, implant related factors, including year of service, implant system, length, 
diameter, surface texture, connection type, restoration type (crown/bridge/overdenture), 
cement/screw retained restorations, cantilever design and use of splinted/non-splinted 
crowns were also recorded. Furthermore, surgical related factors, including guided bone 
regeneration procedure, sinus lift procedure, types of bone graft used, types of membrane 
used, and one-stage or two-stage surgical approach, were also reported. Adverse events 
(restorative complications, biological complications), peri-implant parameters (deepest 
peri-implant probing depth, bleeding on probing, BOP, and RBL after physiologic bone 
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remodeling) and implant survival/success/failure were collected and entered into a database. 
Patient information was protected according to the privacy regulations of the federal Health 
Insurance Portability and Accountability Act of 1996 (HIPAA). The study protocol 
(Appendix I) was reviewed and approved by the Institutional Review Board of the 
University of Michigan (ID number: HUM00102699, Appendix II). 
From the database, the implant success, survival and failure rates and implant and patient 
information were analyzed. Implant failure was defined as any implant removed for any 
reasons during the observation period. Implant survival was defined as any implant still 
functions in patient’s mouth. Criteria used to define implant success (Table I) were 
modified from American Academy of Periodontology Position Paper published in 2000: (1) 
no records of persistent signs/symptoms such as pain, infection, neuropathies, parathesias, 
and violation of vital structures; (2) no record of implant mobility; (3) no continuous peri-
implant radiolucency; (4) negligible progressive bone loss (less than 0.2 mm annually) after 
physiologic remodeling during the first year of function.22 Due to the retrospective nature 
of the current study, patient-centered outcome measurements could not be used as one of 
the parameters to determine implant success.   
The prevalence of peri-implant mucositis and peri-implantitis was also analyzed. The 
definition used to determine the disease identity was based on Koldsland et al. 2010 and 
Renvert et al. 2014.23, 24 However, due to the heterogeneity of the disease definitions, the 
prevalence of the disease based on other criteria5, 25 was also reported and discussed.  
2. Radiographic measurement 
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Periapical or bitewing radiographs taken at the time of prosthesis placement and at least one 
year after implant restoration were used to determine RBL. The radiographs taken at 
prosthesis placement were set as baseline of bone level. The bone level of follow-up 
radiographs was compared to the baseline radiographs. RBL was determined as the bone 
level differences between the baseline and follow-up radiographs. However, if the bone 
level of baseline radiographs was above the junction of rough and smooth surface, the 
junction of rough and smooth surface was used as reference of baseline bone level. All 
measurements were performed by one independent examiner using a computerized 
software (ImageJ 1.48a; Wayne Rasband, National Institutes of Health, Bethesda, MD). 
Intra-examiner reproducibility was analyzed with correlation test for independent samples. 
3. Statistical Analysis 
Outcome analyses will be the overall implant success rate, in association with those 
recorded systemic and local contributing factors of the patients. The associations between 
implant success and the recorded variables were estimated by generalized linear mixed 
model. ORs and estimated RBL were calculated. A p value of 0.05 was used as the level of 
significance. All the statistical analyses were calculated using a computer program (SAS 






Among 685 charts reviewed, 200 charts were included in the study. The 200 charts 
included 550 dental implants placed between 2000 and 2014 UMSOD with a mean follow-
up period of 6.25 years. The study population’s average age was 62.8 ± 9.95 years old 
(ranged 22 to 91), with 101 males and 99 females. The demographic data of the study 
patients were listed as Table II. The characteristics and features of the included implants, 
restorative techniques, and surgical approach, were reported in Table III. Pertaining to 
measurement of RBL, the intra-examiner reproducibility revealed an exact intra-examiner 
correlation of 99%, with a p value of 0.43 for t-test for independent samples, indicating a 
high reproducibility and intra-examiner agreement of the radiographic measurements. 
 
Success, Survival and Failure Rates of Implant Treatment 
At the patient level, 93.5% (187 patients) was determined as survival and 6.5% (13 patients) 
of participants had at least one implant failed. Out of the 187 patients with implant survival, 
151 patients (75.5%) were determined as treatment success, 36 patients (18.0%) had at least 
one implant with progressive peri-implant bone loss (Figure II).  
 
At the implant level, 95.45% (525 implants) of the implants was determined as survival and 
4.55% (25 implants) of the implants was removed. Out of the 525 survival implants, 395 
implants (71.82%) met success criteria and 130 implants (22.63%) presented with 




For the survival implants, the average probing depth was 5.16 ± 1.48 mm, and average 
RBL was 0.66 ± 3.45 mm. Linear regression analysis revealed an estimated annual RBL of 
0.08 mm for the survival implants (Figure IV). For the implants met success criteria, the 
average probing depth was 3.63 ± 0.93 mm, and average RBL was minimal. 
 
Prevalence and Severity of Peri-implant Diseases   
Based on the criteria published by Koldsland et al. 201024 and Renvert et al. 2014,23 the 
prevalence of peri-implant mucositis in our study was 57.5% and 61.64% at the patient 
level and the implant level, respectively. Besides, the prevalence of peri-implantitis was 
61.64% and 16.00% at the patient level and the implant level, respectively (Table IV).   
  
Based on the criteria of the most recently published study by Derks et al.,25 the prevalence 
of peri-implant mucositis in our study was 29.5% at the patient level and 35.8% at the 
implant level; the prevalence of peri-implantitis was 40.0%  and 41.8% at the patient and 
implant level, respectively. If the disease severity is considered, the prevalence of moderate 
to severe peri-implantitis (≥2.0mm RBL with BOP or suppuration) in our study was 12.0% 
at the patient level and 16.0% at the implant level. Mean RBL of implants with peri-
implantitis was 1.99 ± 1.52 mm. For implants with moderate to severe peri-implantitis, 
mean RBL of the implants with peri-implantitis was 3.29 ± 1.74 mm (Table V). 
 
Factors Associated with Implant Success at Patient Level 
Significantly higher ORs associated with implant success at the patient level were found for 
patients who were not smokers at the time of implant placement (OR= 3.68), patients 
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without diabetes (OR= 5.85), patients without psychological disorder (OR= 4.93), patients 
with no previous history of periodontal disease (OR= 7.13), and patients who only received 
single implant placement (OR= 3.58). 
 
After the adjustment of the potential inter-variable influence using regression analysis, all 
aforementioned parameters were still presented statistical significance except for 
psychological disorder (p= 0.17). The complete data of ORs and estimated RBL were 
presented in Table VI.  
 
Factors Associated with Implant Success at Implant Level 
Significantly higher ORs associated with implant success at implant level were found for 
implants placed by faculty instead of residents (OR= 4.40), certain implant system (OR= 
2.26), and rough implant surface (OR= 3.03). In terms of restorative factors, implant-
supported single crowns were found to have higher success rate compared to bridge 
restoration (OR= 3.62). Restorations without the use of cantilever (OR= 6.94) and non-
splinted crowns (OR= 1.93) were also found to significantly contribute to higher success 
rate. Deeper probing depth (OR= 3.51) was also found to be negatively associated with 
implant success.  It is worth mentioning that BOP did not find to be significantly associated 
with implant success (OR= 1.52). 
 
After the adjustment of the potential inter-variable influence using regression analysis, 
provider level (p= 0.0013), restoration type (single crown vs. bridge, p= 0.0468) and 
absence of cantilever (p<0.0001) still presented statistical significance. Also, deeper 
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probing depth (p< 0.0001) was still presented negative association with implant success. 
The data of ORs and estimated RBL were presented in Table VI.  
 
Complication Types and Rates 
The current study recorded 27.5% (151 implants) of restorative complication rate and 
18.0% (99 implants) of biological complication rate among 550 analyzed implants. 
Overdenture attachment loosening presented as the most frequent restorative complication 
(25%). Porcelain and ceramic fracture presented as the second most commonly restorative 
complication followed by loosening of abutment screw. Suppuration and bleeding 





According to American Academy of Periodontology Academy Statement, peri-implant 
mucositis was defined as a disease in which the presence of inflammation is confined to the 
soft tissues surrounding a dental implant with no signs of loss of supporting bone following 
initial bone remodeling during healing. Peri-implantitis has been characterized by an 
inflammatory process around an implant, which includes both soft tissue inflammation and 
progressive loss of supporting bone beyond biological bone remodeling.26 Consensus 
Report of the Sixth European Workshop on Periodontology also defined peri-implant 
mucositis as an inflammatory lesion that resides in the mucosa, while peri-implantitis 
affects the supporting bone.27 Although these definitions reflect the true identify of peri-
implant diseases as infectious diseases, it is difficult for clinicians to make a clinical 
diagnosis accurately if a clear classification is not readily available partly due to biologic 
bone remodeling which occurs immediately following implant placement. The degree of 
biologic bone remodeling depends on several factors, including level of implant placement, 
tissue thickness, implant design and implant surface topography.28-31  
 
A clearer definition for peri-implant diseases is imperative to aid clinicians to diagnose 
peri-implant mucositis and peri-implantitis. Since this definition has not been listed in the 
developed classification system,32 the prevalence of peri-implant diseases is difficult to be 
evaluated. Several clinical trials have introduced different bone level change as threshold to 
define peri-implantitis. In 1986, Albrektsson and co-workers5 described that gradual bone 
loss of 0.2 mm after the first year of function could be considered successful treatment. In 
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2006, Roos-Jansaker et al. 33 introduced three threads of radiographic bone loss as the 
definition of peri-implantitis. Later on, Koldsland et al.24 in an epidemiologic study 
described peri-implantitis as more than 2 mm radiographic bone loss with the presence of 
BOP/suppuration. In this study, the prevalence of peri-implant diseases was reported 
ranging from 11.3% to 47.1%, based on different analyzed population. In 2012, Froum and 
Rosen34 used percentage of bone loss of total implant length as a cut-off point to determine 
severity of peri-implantitis. In this particular study, early peri-implantitis was defined as 
probing depth ≥4 mm with BOP/suppuration and bone loss <25% of the implant length. 
Moderate peri-implantitis was defined as probing depth ≥6 mm with BOP/suppuration and 
bone loss ≥25% but ≤50% of the implant length. Advanced peri-implantitis was defined as 
probing depth ≥8 mm with BOP/suppuration and bone loss >50% of the implant length. In 
2014, a retrospective study by Renvert et al.23 defined peri-implantitis as loss of bone ≥2.0 
mm from the implant platform level to the most coronal level of bone to implant contact 
radiographically, and this study reported a prevalence of peri-implantitis of 39.3% and 
47.8% at implant level and patient level, respectively. Most recently, Derks et al.25 reported 
that 45% of the patients presented with peri-implantitis (BOP/suppuration and bone loss 
>0.5 mm). The study further analyzed moderate/severe peri-implantitis (BOP/suppuration 
and bone loss >2 mm) was seen in 14.5% of patients. These variances of disease prevalence 
highly present a large heterogeneity of the different definitions introduced. Therefore, to 
facilitate a more predictable treatment guideline and accurate diagnosis, a widely accepted 





Based on the definition of Koldsland et al.,22 the current study retrospectively analyzed 550 
dental implants placed in 200 subjects and found that prevalence of peri-implant diseases 
was approximately 69.5% of the patients and 77.6% of the implants. Factors such as 
provider level, restoration type and cantilever design had significant impact on implant 
success. This result was in accordance with recent studies published by Derks et al.25, 35 In 
their studies, history of periodontitis (OR= 3.3), smokers (OR= 2.3), implant length less 
than 10 mm (OR= 3.8), certain implant brands, number of implants placed ≥4 (OR= 15.09), 
prosthetic therapy delivered by general practitioners (OR= 4.27), exhibited higher ORs for 
implant loss or moderate/severe peri-implantitis. Interestingly, our study did not find 
statistical significance on association between implant success and implant length. Recent 
systematic reviews and meta-analysis36, 37 also failed to warrant the influence of implant 
length on implant survival. This result might have been explained by the limited number of 
short implants (<10 mm) included in our study (N=16), various demographic data and 
systemic conditions of participants as well as different study designs. 
 
History of periodontal disease has been widely accepted as a major risk factor for peri-
implant diseases.26 Based on the result of the current study, it represents the highest risk 
(OR= 7.13) among all the identified factors. Several systematic reviews16, 18, 38-40 have also 
addressed the relationship between the history of periodontal disease and peri-implantitis. 
Karoussis et al.39 in 2003 firstly described this finding in a prospective study. The authors 
conjectured that periodontal pathogens recognized in residual periodontal pockets of the 
remaining dentition might be sources of infection for the subsequent bacterial colonization 
of newly installed sterile implants. Also, individual host susceptibility might be different 
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when pathogenic bacteria are present. However, although a history of periodontal disease 
might play a role in development of peri-implantitis, limited clinical trials were conducted 
to evaluate the difference in bone loss and implant success between populations with or 
without history of periodontitis.38 Therefore, future well-designed clinical trials are needed 
to further warrant this linkage.  
 
Smoking has also been identified as another risk factor of peri-implant disease.15, 16, 41 An 
OR ranging from 3.6 to 4.6 has been reported.26 On the cellular level, tobacco smoke can 
exert its effects on the periodontium and peri-implant tissues through local and systemic 
mechanisms. Smoking causes a decrease in polymorphonuclear neutrophils (PMN) 
chemotaxis and phagocytosis,42, 43 as well as activation of pro-inflammatory mediators such 
as IL-6, TNF-α and IL-1β.44 Smoking also causes peripheral vasoconstriction, leading to 
local ischemia and decreased nutrient flow. This characteristic has an effect on the make-up 
of the pathogenic subgingival bacterial profile, which was shown to have increased levels 
of periodontal pathogens in smokers compared to non-smokers.45 In a systematic review 
published by Klokkevold and Han,16 the implant success rates reported for smokers ranged 
from 52% to 100% with a pooled estimate of 77% for smokers compared to a pooled 
estimate of 91% for nonsmokers. The authors further discussed the potential relationship 
between smoking and bone quality as well as implant surface topography. Similarly, a ten 
year follow-up study published by Rasperini et al.46 found that cigarette smoking negatively 
influences the long-term implant outcomes and marginal bone levels in periodontally 
healthy or compromised patients. Although a few studies have stated that the use of rough-
surface implants might minimize the effect of smoking on implant success,47 this theory 
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still needs more clinical trials to prove. Also, the potential benefit of smoking cessation to 
implant survival/success is rarely evaluated in the currently available literature. A proposed 
protocol by Bain48 involved complete cessation of smoking for 1 week before and 8 weeks 
after initial implant placement. However, this protocol is lack of evidence support and 
might merely represent a personal opinion. Therefore a solid influence of smoking 
cessation on implant treatment outcome still cannot be drawn at this point. 
 
The role of diabetes in development of peri-implantitis is controversial. The hyperglycemic 
environment leads to capillary basement membrane thickening, impaired oxygen diffusion 
and waste elimination. PMN migration is also diminished, which impairs the host defense 
mechanism and an overall altered immune function against infection.49 In addition, 
hyperglycemia also leads to production and accumulation of advanced glycation end 
products (AGEs). AGEs bind to monocytes and macrophages, causing them to release more 
pro-inflammatory cytokines such as IL-1β, TNF-α and PGE2, which result in tissue 
destruction.50 However, most systematic reviews refuted diabetes as a risk factor of peri-
implantitis and implant failure15, 16, 41, 51 and it might result from the fact that most 
participants in these selected studies were patients with well-controlled diabetes. In the 
current study, an OR of 5.85 was identified and indicated a significant association between 
diabetes and implant failure. From the study result, it can be speculated that diabetes in our 
study population was not well controlled during the study period. 
 
Another interesting finding of the current study is increased number of implant placed in a 
single patient is associated with lower implant success rate. This finding was consistent 
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with the result published by Derks et al.25 In their study, patients who received 4 or more 
than 4 implants presented with a higher incidence of moderate to severe peri-implantitis. A 
more strenuous maintenance protocol might be beneficial for patients who have received 
multiple implants. 
 
Two prosthetic factors were identified as risk indicators for implant failure: the use of 
cantilever (OR= 6.94) and the design of bridge (OR= 3.62). When cantilever design is used, 
the highest stresses were located at the ridge crest on the distal surface of the distal 
implant,52, 53 which might trigger more peri-implant bone loss. A recent systematic review54 
concluded that the use of cantilevers into implant-borne prostheses may be associated with 
a higher incidence of minor technical complications (9.7% without cantilevers vs. 20.3% 
with cantilevers). In this study, lower 5-year implant survival rate for fixed prostheses with 
cantilevers (91.9%) was also noted compared to the ones without cantilevers (95.8%). 
Pertaining to the design of implant-supported restorations, studies investigating the 
difference between bridge design and single crown restorations are limited. Although 
current study reported a significant negative impact of bridge restorations on implant 
success, Pjetursson et al. 4 reported 89.4% and 86.7% estimated survival rate after ten years 
of service for implant-supported single crowns and fixed partial dentures, respectively. 
Their study revealed a long-term comparable implant outcomes could be expected between 
single crowns and bridge restorations. The different result between current study and 
Pjetursson et al. might result from the primary outcome measurement. It is worth noting 
that in the current study, we aimed to identify the factors related to implant success, instead 
of implant survival, since implant success is more clinically relevant and important to 
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clinicians. This finding might shed a light to restorative clinicians in the future to 
understand the importance of prosthetic design related to implant success. Therefore, future 
prospective clinical trials are needed to further investigate the association between 
prosthetic design and implant success. 
 
Providers’ level of experience is another significant factor for implant success. Current 
study revealed more experienced surgeons (faculty members) demonstrated higher implant 
success rate compared to less experienced surgeons (residents). This result is consistent 
with previous study published by Derks et al.,25 which reported a less experienced provider 
population (general practitioners) exhibited higher OR for moderate/severe peri-implantitis 
compared to a more experienced provider population (specialists).  
 
Recently, a few studies reported certain implant systems might contribute to higher late 
implant loss.25, 35 The authors speculated that reasons such as progressive marginal bone 
loss, damages on the interface between the implant and the bone tissue, or harm to the 
implant, might be the causes of this phenomenon. However, the present study failed to 
warrant the influence of implant system or surface on implant outcomes. This might result 
from the lack of sample size for certain implant surface/system in the current study. Also, 
comparing the outcomes of various implant brand might not be meaningful and 
representative since each implant brand has been evolving the macro- and micro- implant 
design as well as surface topography of its products. Therefore, future studies should focus 
on comparing various methods of implant macro- and micro- designs and surface treatment 




Since most currently available implant-related studies introduced probing depth and BOP 
as important parameters to evaluate implant outcomes, the current study also examined the 
association between these two parameters and implant success. Interestingly, the result 
showed that deepest probing depth (OR= 3.51, p value < 0.0001) was significantly 
negatively associated with implant success and mean probing depth for success implant was 
3.63 ± 0.93 mm, for survival implant was 5.16 ± 1.48 mm. Therefore, probing depth less 
than 4 mm should be considered as one of the guidelines to warrant peri-implant tissue 
health. 
 
On the contrary, BOP failed to show the significant association related to implant success 
(OR= 1.52, p value= 0.0833). This finding indicated that clinicians should cautiously 
determine the peri-implant tissue health in the future when introducing BOP as one of the 
criteria. Since peri-implant tissue is more fragile to probing force and the attachment is not 
as firm as periodontium,55 presence of BOP might not accurately represent the 
inflammatory status of the peri-implant tissues. Previous studies have reported that BOP 
around dental implants were shown to be greater despite lower plaque scores and fewer 
signs of inflammation.56, 57 Also, absence of BOP has been reported as a good indicator of 
healthy peri-implant mucosa but presence of BOP might have limit diagnostic value.58 
Therefore, presence of BOP, based on the result of the present study, has been noted as a 




Based on American Academy of Periodontology Academy Statement,26  absence of BOP is 
not an indicator to warrant implant success. However, most published articles still 
introduced BOP around peri-implant tissues as one of the criteria to determine peri-implant 
diseases. Since several studies59-61 have shown that peri-implant mucositits is a reversible 
inflammatory process if treated appropriately, therefore implants with peri-implant 
mucositis should not be considered as unsuccessful. In other words, implant success is not a 
term to describe implants free of peri-implant disease, it represents implants without 
progressive RBL and suppuration. These successful implants might present healthy or 
inflamed peri-implant soft tissues, however this inflammation could be resolved by 
providing non-surgical/surgical treatment. 
 
In the present study, most implant failures occur within the first five years (84.6%) after 
final restoration placement. It represents that using 1-year follow-up after final restoration 
placement to determine implant outcomes might be insufficient. A longer follow-up (>1 
year) after placement of definite restoration is recommended to identify the pattern of RBL 
and further determine the outcome of implant treatment. In addition, negligible RBL after 
the first year of implant loading, probing depth of peri-implant soft tissue less than 4mm, 
and free of implant related complications should be considered as a new definition of 
implant success. 
  
Several limitations exist in the present study: (1) due to the retrospective nature, no patient 
centered outcomes, such as treatment satisfaction or esthetics, could be retrieved; (2) many 
crucial clinical parameters related to peri-implant tissue health, such as oral hygiene 
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status,26 the amount of keratinized tissue,62, 63 peri-implant tissue thickness29, 30 and 
occlusion,26, 55 could not be evaluated; (3) the reported prosthetic and biological 
complication rates might be lower than the previously published data64, 65 since the 
complication rates were calculated based on the report of treatment notes and chart review 
retrospectively; (4) impact of maintenance protocol after implant placement / definite 
restoration on implant outcomes could not be analyzed; (5) the outcomes of various implant 
surface/brand could not be comprehensively evaluated due to limited sample size for 
certain implant surface/system. 
 
The current study also shed light on several aspects of future study directions. First, a 
widely accepted classification/diagnosis system for peri-implant diseases should be 
facilitated as soon as possible since the disease prevalence is difficult to be determined 
owing to heterogeneity of currently available definitions of the diseases. Second, the 
relationship between smoking cessation and implant success needs to be identified. Third, 
the influence of smoking on peri-implant bone loss should be investigated. Fourth, more 
clinical trials investigating the influence of implant-supported bridges and single crowns 
restorations on implant outcomes are needed. Fifth, the effect of cantilever design on peri-
implant bone level change should be warranted. Sixth, there is a lack of large multi-center 
clinical trials to evaluate implant outcomes among various implant surface topography and 





The data of the present study suggest that smoking, diabetes, previous history of 
periodontal disease and multiple implant placement are negative indicators for implant 
success. Furthermore, provider level, restoration type and cantilever design also have 
significant impact on implant success. Deep probing depth could be used as an indicator of 
peri-implant inflammation but not BOP.    
 
In addition, negligible RBL after the first year of implant loading, probing depth of peri-
implant soft tissue less than 4mm, and free of implant related complications should be 
considered as a new definition of implant success. A longer follow-up (>1 year) after 
placement of definite restoration is recommended to identify the pattern of RBL and further 
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Table II: Demographic data of the selected participants 
 
Total: 200 patients (100%) 
Gender Male: 101 (50.5%) Female: 99 (49.5%) 
Age 62.8 ± 9.95 years old, ranging 22 to 91 
Smoking status Yes: 72 (36.0%) No: 128 (64.0%) 
Diabetes Yes: 46 (23.0%) No: 154 (77.0%) 
Obesity (BMI>30) Yes: 53 (26.5%) No: 147 (73.5%) 
Alcohol abuse history Yes: 8 (4.0%) No: 192 (96.0%) 
Osteoporosis Yes: 21 (10.5%) No: 179 (89.5%) 
History of psychological disorder Yes: 16 (7.8%) No: 184 (92.2%) 
HTN (medication control or >140/90) Yes: 70 (35.0%) No: 130 (65.0%) 
History of periodontal disease Yes: 104 (52.0%) No: 96 (48.0%) 





Table III: Characteristics and features of the included implants, restorative techniques, and 
surgical approach 
 
Total implants: 550 
Follow-up year(s) Average 6.25 ± 3.61 years, ranging 1 to 14 
Location  Maxillary anteriors: 21, Maxillary posteriors: 196,  
Mandibular anteriors: 6, Mandibular posteriors: 327 
Implant length Average 11.40 ± 1.48 mm, ranging 7.0 to 15.0 
Implant diameter Average 4.32 ± 0.51 mm, ranging 3.3 to 6.0 
Department placed Perio: 518, Prostho: 24, Endo: 8 
Provider level Faculty: 69 Resident: 481 
System Nobel Biocare: 301, Zimmer: 101, Straumann: 104 
BioHorizons: 21, Dentatus: 6, 3i: 13, Astra: 4  
Surface Rough: 466 Smooth: 84 
Radiographic bone loss Average 0.84 ± 1.38 mm, ranging 0 to 9.5 
Deepest probing depth Average 4.60 ± 1.73 mm, ranging 3 to 12 
Bleeding on probing Yes: 345 (62.73%) No: 205 (37.27%) 
Abutment connection Flat: 509 Platform switching:  41 
Restoration type Crown: 456 Bridge: 86 Overdenture: 8 
Prosthesis connection type Cement-retained: 459 Screw-retained: 91 
Cantilever attached Yes: 26 No: 524 
Splinted restoration Yes: 298 No: 252 
Ridge augmentation 
performed (GBR) 
Yes: 156 No: 394 
Sinus lift performed Yes: 60 No: 490 
Staged approach 1-stage: 243 2-stage: 307 
Restorative complications Yes: 152 No: 398 






Table IV: Treatment outcomes at patient level and implant level based on Koldsland et al. 

















≥2.0mm RBL: 5.5% 
(11/200) 












Table V: The prevalence of peri-implant diseases based on the criteria published by Derks 














≥0.5mm RBL: 33.50% 
(67/200) 
≥2.0mm RBL: 5.50% 
(11/200) 
6.50% (13/200)  








≥0.5mm RBL: 37.28% 
(205/550) 
≥2.0mm RBL: 11.45% 
(63/550) 
4.54% (25/550) 




Table VI: Odds ratios and estimated RBL related to implant success; factors presented 
statistically significant difference after regression adjustment were marked in bold. 
 
Odds Ratio P value Estimated RBL (mm) 
Systemic Factors 
   
Age 1.83 0.7280 0.0006 
Gender 1.37 0.0605 0.1327 
Smoking status 3.68 <0.0001 0.7157 
Diabetes 5.85 <0.0001 0.5315 
Obesity (BMI>30) 2.37 0.0824 0.1972 
Alcohol abuse history 1.01 0.9927 0.7613 
Osteoporosis 1.31 0.1377 0.0545 
History of psychological disorder 4.93 0.0109* 1.3480 
Hypertension 1.03 0.0608 0.0368 
History of periodontal disease 7.13 <0.0001 0.7106 
Implant/Clinical Factors 
   
Number of implants 3.58 0.0010 0.6693 
Follow-up year(s) 1.05 0.6542 0.2516 
Location  1.13 0.9849 0.2516 
Implant length 1.00 0.9912 0.0004 
Implant diameter 1.45 0.1229 0.0962 
Department placed 1.16 0.1544 0.0037 
Provider level 4.40 0.0021 0.5925 
System 2.26 <0.0001* 0.8145 
Surface 3.03 0.0122* 0.5645 
Deepest probing depth 3.51 <0.0001 0.4336 
Bleeding on probing 1.52 0.0833 0.4570 
Restorative Factors 
   
Abutment connection 1.38 0.2739 0.4374 
Restoration type (single crown vs. 
bridge) 
3.62 0.0312 0.9160 
Prosthesis connection type 1.08 0.6932 0.2055 
Cantilever attached 6.94 0.0019 2.0297 
Splinted restoration 1.93 0.0178* 0.5652 
Staged approach 1.35 0.3253 0.2664 
Surgical Factors 
   
Ridge augmentation performed 1.30 0.4100 0.2738 
Sinus augmentation performed 1.88 0.0585 0.8474 
Various bone grafting materials 1.32 0.8938 0.1450 
Various barrier materials 1.14 0.9695 0.4634 
*: No statistically significant difference was detected after regression analysis. 
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Table VII: Incidence of restorative and biological complications 
 




Porcelain/ceramic fracture 14.18% (78/550) 
Abutment screw loosening 7.27% (40/550) 
Prosthesis screw loosening 2.73% (15/550) 
Open contact 2.00% (11/550) 
Abutment screw fracture 0.91% (5/550) 
Biological Complications Incidence 
Suppuration 9.82% (54/550) 
Bleeding related complications 6.55% (36/550) 
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Figure IV: Result of linear regression analysis showed an estimated annual RBL of 0.08 
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Introductory Statement  
Implant therapy is a widely adopted treatment option for replacing missing teeth; however, 
biological, mechanical or iatrogenic factors might trigger early or late failure of dental 
implants.1-3 Early implant failure is mostly caused by not achieving implant 
osseointegration after its insertion while late implant failure is largely related to 
unfavorable loading or occlusion, peri-implant disease or non-ideal prosthetic design.4 
Several local and systemic factors have been identified to be associated with an increased 
risk of implant failure, such as smoking,5, 6 diabetes,7 previous history of periodontal 
diseases,5, 6, 8 poor plaque control,9 occlusal overload.10. However, limited evidence is 
present to demonstrate the rate and cause of implant failure. Therefore, the aim of this 
retrospective study is to investigate implant failure rate in a single center with multiple 
different training backgrounds; surgeons and prosthodontists and further identify the 
potential systemic/local risk factors associated with implant failure. 
General Investigational Plan 
A retrospective study is planned to investigate implant failure rate and to identify the 
potential systemic/local risk factors associated with implant failure. The clinical charts and 
radiographs of patients who underwent dental implant placement at the University of 
Michigan School of Dentistry (UMSOD) from March 2000 through March 2014 will be 
examined and analyzed. Data regarding the implant manufacturer, location in the mouth, 
implant diameter, implant length, implant placed with vertical/horizontal bone 
augmentation procedures, smoking status, history of diabetes, history of previous 
periodontal diseases, reasons of implant removal, implant survival time, as well as surgeons’ 
and prosthodontists’ experience, will be collected and entered into a database. Patient 
information will be protected according to the privacy regulations of the federal Health 
Insurance Portability and Accountability Act of 1996 (HIPAA). 
Outcome analyses will be the cumulative implant survival and success rates, in association 
with those recorded systemic and local contributing factors of the patients. Statistical 
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analyses will be introduced to analyze cumulative implant survival rate as well as 





Dental implants have been widely used in partial or full edentulous arches for oral 
rehabilitation. Long-term prospective studies and systematic reviews have demonstrated 
that more than 95% survival rate could be expected after 5-year of loading.2, 11 However, 
several reasons might still contribute to early or late failure of dental implants such as 
biological, mechanical or iatrogenic factors.1-3 
Criteria to determine survival and success of dental implants have been reported in several 
studies.12-15 Based on the International Congress of Oral Implantologists (ICOI) Pisa 
Consensus Conference report,14 survival represents that the implant is still kept in the 
mouth instead of being removed, and should not present mobility, pain on function or bone 
loss more than 1/2 of implant length. Albrektsson et al.12 defined that a successful implant 
must present no mobility, no peri-implant radiolucency, bone loss less than 0.2 mm per 
year after the first year of loading, and no persistent pain, discomfort or infection. Failure of 
a dental implant is determined when an implant demonstrates mobility, pain on function, 
uncontrolled exudates, or severe bone loss.14 In this case, the implant should be removed. 
The concept of “osseointegration,” defined as “a direct functional and structural connection 
between living bone and the surface of a load carrying implant,” was originally introduced 
by Dr. Branemark.16 This finding has further influenced the evolution of implant dentistry 
on implant surface modifications, grafting materials, and surgery techniques. However, 
early implant failure mostly involves the failure of achieving osseointegration during initial 
healing process after implant placement. It might result from poor bone quality or quantity, 
patient’s medical condition, smoking, infection, overheating of the bone, compression bone 
necrosis, lack of primary stability as well as poor experience and skills of surgeons.4, 17  
On the contrary, late implant failure is related to unfavorable loading or occlusion, peri-
implant disease and non-ideal prosthetic design.4 Fu et al.10 elaborated the occlusal 
considerations and management of complications when restoring a dental implant. It was 
summarized that implant stability, radiographic bone levels, loss of attachment, and 
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loosening and fractures of implant fixtures and prosthetic components, could be used to 
assess the influence of occlusal overloading. However, although most of the 
mechanical/prosthetic complications are reversible by means of replacement or adjustment 
of restorative counterparts, currently there is still a lack of effective treatment modalities for 
managing peri-implantitis.18, 19  
Several local and systemic factors have been proposed and associated with an increased 
risk of peri-implantitis, such as smoking,5, 6 diabetes,7 previous history of periodontal 
diseases,5, 6, 8 poor plaque control,9 and occlusal overload.10 Other predisposing local factor 
related to peri-implantitis is retained excess cement, which leads to potential biological 
complications and marginal bone loss.20, 21 It has been reported that a trend of bone loss 
exceeding 2 mm was found more in cement-retained restorations compared to screw-
retained restorations,21 which may compromise the future survival of the implants and 
restorations. 
II. Study Aim 
The aim of this retrospective study is to investigate the implant survival, success and failure 
rates in a single center with multiple surgeons and prosthodontists and to identify the 
potential systemic/local risk factors associated with implant failure. 
III. Hypothesis 
Implants placed in patients with systemic/local risk factors, such as smoking, diabetes, 
previous history of periodontal diseases, poor plaque control, symptoms/signs of occlusal 
overload, required bone augmentation, less experienced surgeon, and cement-retained 
multi-unit restorations, are more susceptible bone loss and failure. 
IV. Materials and Methods 
1. Data Retrieval  
In this retrospective study, the clinical charts and radiographs of patients who underwent 
dental implant placement at the University of Michigan School of Dentistry (UMSOD) 
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from March 2000 through March 2014 will be reviewed. A minimal of 200 charts are 
planned to be included in this retrospective radiographic study. The charts will be reviewed 
in a random order and once 200 charts are reviewed that have the inclusion criteria, no 
more charts will be reviewed. Subjects who are at least 18 years old that have had at least 
one implant placed at UMSOD with at least a one-year follow-up periapical radiograph(s) 
of the implant(s) will be included. Data regarding patients’ and implants’ information 
(patients’ study number, location of the tooth number, age, gender, faculty/resident 
provider level and provider department), year of implant placed, systemic conditions 
including past history of smoking status, diabetes mellitus, alcohol consumption, 
osteoporosis, depression, obesity, hypertension, and past history of periodontal diseases, 
restorative related factors (implant system, length, diameter, surface texture, connection 
type, restoration type such as crown/fixed dental prosthesis/overdenture, cement/screw 
retained prosthesis, cantilever, splinted/non-splinted crowns), surgical related factors 
(simultaneous guided bone regeneration procedure, sinus lift procedure, types of bone graft 
used, types of membrane used, staged surgical approach, insertion torque), adverse event 
(restorative complications, biological complications), peri-implant parameters (deepest 
peri-implant probing depth, bleeding on probing, first-year radiographic bone loss and 
annual radiographic bone loss after first year service of implant restoration, if available) 
and implant survival/success/failure will be collected and entered into a database. 
From this database, the cumulative survival rate and implant and patient information will be 
analyzed. Implant failure is defined as any implant removed for any reason during the 
observation period. Early implant failure is defined as implant removed before final 
restoration completed, and late implant failure is defined as implant removed after final 
restoration completed. Implant survival is defined as an implant still in function in the 
patient’s mouth. Implant success is defined based on American Academy of Periodontology 
Position Paper in 2000: (1) absence of persistent signs/symptoms such as pain, infection, 
neuropathies, parathesias, and violation of vital structures; (2) implant immobility; (3) no 
continuous peri-implant radiolucency; (4) negligible progressive bone loss (less than 0.2 
mm annually) after physiologic remodeling during the first year of function; and (5) 
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patient/dentist satisfaction with the implant supported restoration.22 The study protocol will 
be reviewed and approved by the University of Michigan Institutional Review Board. 
2. Statistical Analysis 
Outcome analyses will be the cumulative implant survival rate, in association with those 
recorded systemic and local contributing factors of the patients. Implant survival will be 
estimated. The associations between implant survival/success/failure rates and the recorded 
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